TP53 and nasopharyngeal carcinoma: Meanwhile, compared to the control group, the HMF treatment group showed significantly upregulated p-p53/p53, indicating that HMF inhibited NPC cell growth and proliferation through the AMPK/p53 signaling pathway (*p < 0.05 and **p < 0.01).